Michael D. Wortley, Chief Legal Officer at REATA PHARMACEUTICALS INC (RETA), sold 53,880 shares at $98.60 ($5.4M) on 2019-03-05, disclosed to the SEC on 2019-03-07.
Open-market sale of $5.4M RETA by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.60 | 8,489 | $837K | 15.5% |
| 2 | $98.60 | 8,489 | $837K | 15.5% |
| 3 | $99.48 | 7,019 | $698K | 12.9% |
| 4 | $99.48 | 7,019 | $698K | 12.9% |
| 5 | $100.42 | 5,041 | $506K | 9.4% |
| 6 | $100.43 | 5,041 |
| $506K |
| 9.4% |
| 7 | $101.69 | 300 | $31K | 0.6% |
| 8 | $101.69 | 300 | $31K | 0.6% |
| 9 | $102.51 | 4,161 | $427K | 7.9% |
| 10 | $102.51 | 4,161 | $427K | 7.9% |
| 11 | $103.54 | 1,830 | $189K | 3.5% |
| 12 | $103.54 | 1,830 | $189K | 3.5% |
| 13 | $104.14 | 100 | $10K | 0.2% |
| 14 | $104.15 | 100 | $10K | 0.2% |
| Total | $100.17 avg | 53,880 | $5.4M | 100% |
| Filing → |
| RETA | SELL | 2023-03-08 | $35K | — | Filing → |
| RETA | SELL | 2023-03-06 | $380K | — | Filing → |
| RETA | SELL | 2020-11-12 | $18.0M | — | Filing → |